Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.29 - $0.89 $7,335 - $22,513
25,296 New
25,296 $7,000
Q1 2022

May 16, 2022

SELL
$1.07 - $2.71 $16,351 - $41,414
-15,282 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$1.87 - $2.91 $28,577 - $44,470
15,282 New
15,282 $29,000
Q1 2018

May 15, 2018

SELL
$3.65 - $5.2 $47,183 - $67,220
-12,927 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$3.4 - $4.15 $43,951 - $53,647
12,927
12,927 $47,000

About APPLIED GENETIC TECHNOLOGIES CORP


  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.